Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
1 in 7 Americans Plan To Use a GLP-1 Medication in 2026 Overall, one in seven Americans say they expect to use a GLP-1 medication such as Ozempic or Wegovy in 2026
Amid this surge, Novo Nordisk, the company behind GLP-1 drugs Ozempic and Wegovy, has experienced a remarkable rise in its stock price, from roughly $50 per share in 2022 to upwards of $142 in June 2024
For patients with type 2 diabetes, blood glucose improvements become apparent within weeks, with hemoglobin A1c reductions evident after 12 to 16 weeks
Konzo: a distinct disease entity with selective upper motor neuron damage
US$ 24.41
US$ 27.37
US$ 24.09
US$ 28.76
